Comparison

Insurance vs Self-Pay Tirzepatide

Check coverage first, always

The single largest cost variable in this category is not which provider you choose. It is whether your insurance covers a brand GLP-1 for your indication. Where it does, the copay can be roughly $25 a month, which no self-pay route approaches.

Many plans exclude weight-management indications specifically while covering the same molecules for type 2 diabetes. That distinction is worth establishing precisely, because the answer to "is Wegovy covered" and "is semaglutide covered for my diagnosis" can differ.

What to establish, in order

1. Is the drug on your plan's formulary at all? Check for Zepbound and Wegovy by name.
2. Is the exclusion indication-specific? Weight management is frequently excluded where diabetes is covered.
3. What are the prior-authorisation criteria? Many plans cover with documented BMI and comorbidities, which is a form to complete rather than a refusal.
4. Is there a step-therapy requirement? Some plans require trying an older agent first.
5. What is the copay at each tier? A covered drug on a specialty tier can still be expensive.

The self-pay ladder, for comparison

$110 to $147 for compounded microdose programmes, below any studied dose. $149 for approved oral orforglipron or oral Wegovy tablets at starting doses. $169 to $215 for the lower band of compounded standard injectables. $299 to $449 for brand Zepbound direct from LillyDirect. $278 to $399 for the upper band of compounded programmes, which overlaps the brand band entirely.

Where self-pay beats a bad insurance outcome

If your plan excludes weight management and prior authorisation fails, self-pay is the market. In that case the comparison worth running is manufacturer-direct against compounded — and manufacturer-direct is now competitive in a way it was not eighteen months ago.

What is rarely worth doing is buying a brand drug through a telehealth platform at retail markup. Our dataset contains brand Wegovy at $1,794 a month all-in where NovoCare sells it direct for $349.

Flat-rate structures make dose escalation financially neutral. NexLife holds one price across every covered dose, from $186 a month. Its plan pages state the terms before intake.

Questions readers actually ask